scholarly journals Irish injecting drug users and hepatitis C: the importance of the social context of injecting

2004 ◽  
Vol 34 (1) ◽  
pp. 166-172 ◽  
Author(s):  
B. P Smyth
Keyword(s):  
Hepatitis C ◽  
Social Context ◽  
Drug Users ◽  
Injecting Drug Users ◽  
The Social

scholarly journals Risk factors for hepatitis C virus infection among injecting drug users in Sydney.

1994 ◽  
Vol 70 (5) ◽  
pp. 321-324 ◽  
Author(s):  
I van Beek ◽  
R Buckley ◽  
M Stewart ◽  
M MacDonald ◽  
J Kaldor
Keyword(s):  
Risk Factors ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hepatitis C Virus Infection

Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics

2008 ◽  
Vol 137 (7) ◽  
pp. 980-987 ◽  
Author(s):  
M. A. BALOGUN ◽  
N. MURPHY ◽  
S. NUNN ◽  
A. GRANT ◽  
N. J. ANDREWS ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Drug Users ◽  
Multivariable Analysis ◽  
Injecting Drug Users ◽  
Hcv Rna ◽  
Cross Sectional ◽  
Prevalence Studies ◽  
Genitourinary Medicine ◽  
Cross Sectional Design ◽  
Type 3

SUMMARYSurveillance reports and prevalence studies have indicated that injecting drug users (IDUs) contribute more to the hepatitis C epidemic in the United Kingdom than any other risk group. Information on both the prevalence and incidence of hepatitis C in IDUs is therefore essential to understanding the epidemiology of this infection. The prevalence of hepatitis C in specimens from the Unlinked Anonymous Prevalence Monitoring Programme collected in 1995, 1996, 1998, 1999, 2000, and 2001 was determined using residual syphilis serology specimens from IDUs attending 15 genitourinary medicine (GUM) clinics in and outside London. These specimens were tested for antibodies to hepatitis C virus (anti-HCV). Using this cross-sectional design, anti-HCV-negative specimens were tested for HCV RNA to identify incident infections during the ‘window’ period of infection, and thus to estimate HCV incidence. Results of the multivariable analysis showed that there was marked variation in prevalence by clinic (P<0·0001) and age (P<0·0001). Overall the majority of infections were in males and the overall prevalence in injectors declined over the study period from 36·9% to 28·7%. The annual incidence in these injectors was estimated as being 3·01% (95% CI 1·25–6·73). Over the study period HCV incidence decreased by 1·2% per year. Genotyping of the incident infections identified the most common genotype as type 1 with type 3 being more frequently seen after 1998. Of the prevalent infections, genotype 1 was the most common. The study has confirmed a higher prevalence of anti-HCV in IDUs in the London area compared to those outside London. How representative of the current injecting drug user population are IDUs attending GUM clinics is unclear. Even so, such studies allow prevalence and incidence to be estimated in individuals who have ever injected drugs and inform ongoing public health surveillance.

128 HEPATITIS C INFECTION, CLEARANCE AND REINFECTION IN A COHORT OF INJECTING DRUG USERS – A HIGHLY DYNAMIC PROCESS

2010 ◽  
Vol 52 ◽  
pp. S57
Author(s):  
M. Hellard ◽  
R. Sacks Davis ◽  
T. Spelman ◽  
P. Higgs ◽  
A. Pedrana ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Dynamic Process ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hepatitis C Infection

scholarly journals Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil

2010 ◽  
Vol 105 (3) ◽  
pp. 299-303 ◽  
Author(s):  
Maria Betânia S Silva ◽  
Tarcísio M Andrade ◽  
Luciano K Silva ◽  
Itatiana F Rodart ◽  
Gisele B Lopes ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Users ◽  
Injecting Drug Users

scholarly journals Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

2011 ◽  
Vol 55 (1) ◽  
pp. 76-85 ◽  
Author(s):  
Jason Grebely ◽  
Gail V. Matthews ◽  
Margaret Hellard ◽  
David Shaw ◽  
Ingrid van Beek ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hcv Infection ◽  
Adherence To Treatment
Sign in / Sign up

Export Citation Format

Share Document